Imidazopyridine derivatives

A compound of formula (I)

• wherein,
• Ra, Rb and Rd are independently selected from hydrogen, hydroxy, halogen, cyano, nitro, —COR1, —COOR1, —CONH2, —NR1R2, —C1-C8 alkyl, halo-C1-C8 alkyl and —C1-C8 alkoxy;
• Rc is halogen or heteroaryl;
• Re is hydrogen, —C1-C8 alkyl, —C6-C14 aryl or heteroaryl;
• Q is —SO2, —C(O)NR1 or —C(S)NR1;
• Rf is —C1-C8 alkyl, —(CR1R2)p—C3-C8 cycloalkyl, —(CR1R2)p—C6-C14 aryl, —(CR1R2)p heterocyclyl, —(CR1R2)pheteroaryl, —C3-C8cycloalkyl, —C6-C14aryl, heteroaryl or heterocyclyl;
• R1 and R2 are independently selected from hydrogen and lower alkyl;
• p is independently an integer from 1 to 3;
• with the proviso that when Q is —SO2, then Rc is not halogen;
• wherein each of the above alkyl, haloalkyl, alkoxy, cycloalkyl, aryl, heteroaryl and heterocyclyl are unsubstituted or substituted with one or more of the same or different groups selected from halogen, hydroxy, carbonyl, carboxy, ester, ether, acyl, acyloxy, cyano, amino, amide, imino, alkylthio, thioester, sulfonyl, nitro, —C1-C6 alkyl, halo-C1-C6 alkyl, halo-C1-C6 alkoxy, —C1-C6 alkoxy, haloalkoxy, —C3-C8 cycloalkyl, —(CR1R2)p-aryl, —C6-C10 aryl, —NHCOMe, —S(O)2Me, aryloxy, heterocyclyl and heteroaryl;
• or
• a stereoisomer, tautomer, N-oxide or a pharmaceutically acceptable salt thereof.